To verify the overexpression of LCN2 in cervical cancer, we performed immunohistochemistry (IHC) on 90 clinical specimens, including those from SCC (n = 43), AD (n = 28), and adenosquamous cell carcinoma (ADSCC) (n = 19) patients. The gene discussed is LCN2; the disease is cervical cancer.